Statistical Methods in Clinical Trials and Drug Development (Q166750): Difference between revisions

From geokb
(‎Created a new Item: Added new OpenAlex topic claimed by USGS staff from API)
 
(‎Changed label, description and/or aliases in en, and other parts: modified description with assistance from Llama 3.1)
description / endescription / en
This cluster of papers covers a wide range of statistical methods and design considerations in the context of clinical trials and drug development
Statistical methods & designs for clinical trials and drug development.

Revision as of 13:14, 30 August 2024

Statistical methods & designs for clinical trials and drug development.
  • False Discovery Rate
  • Adaptive Designs
  • Noninferiority Trials
  • Biomarkers
  • Phase I Trials
  • Multiple Testing
  • Bayesian Methods
  • Sample Size
  • Composite Endpoints
  • Pharmacokinetic/Pharmacodynamic Modeling
Language Label Description Also known as
English
Statistical Methods in Clinical Trials and Drug Development
Statistical methods & designs for clinical trials and drug development.
  • False Discovery Rate
  • Adaptive Designs
  • Noninferiority Trials
  • Biomarkers
  • Phase I Trials
  • Multiple Testing
  • Bayesian Methods
  • Sample Size
  • Composite Endpoints
  • Pharmacokinetic/Pharmacodynamic Modeling

Statements